Sumitomo Chemical is borrowing ¥40bn in the public bond market to pay off debt it already owes, not to fund anything new. A shelf registration supplement filed with the Kanto Local Finance Bureau on August 27 sets pricing for two unsecured note tranches: ¥20bn of five-year bonds (the 69th series) carrying a 2.659% coupon and maturing September 4, 2031, and ¥20bn of two-year bonds (the 70th series) at 2.048%, maturing September 4, 2028. Payment for both tranches is due September 4, 2026.
| Series | Amount | Coupon | Maturity |
|---|---|---|---|
| 69th series (5-year) | ¥20bn | 2.659% | September 4, 2031 |
| 70th series (2-year) | ¥20bn | 2.048% | September 4, 2028 |
| Total | ¥40bn | - | Payment due September 4, 2026 |
The use of proceeds is unusually specific for a filing of this type. Net proceeds after ¥153mn in issuance costs come to ¥39.847bn, and the company says the entire amount will go toward repaying commercial paper that matures by the end of September 2026. In plain terms, Sumitomo Chemical is terming out short-dated financing into five- and two-year money at fixed rates, a standard treasury move but one that gives outside observers a genuine data point on what an A-range Japanese industrial credit currently pays to borrow across two different maturities.
Both tranches carry ratings from Japan's two domestic agencies: A+ from the Japan Credit Rating Agency (JCR) and A from Rating and Investment Information (R&I), both assigned on the filing date. Neither rating implies a view on price risk or market liquidity, and both agencies note their opinions can be revised as Sumitomo Chemical's business or the wider chemical sector shifts.
The underwriting syndicates differ slightly by tranche. On the five-year notes, Nomura Securities led with ¥6bn, followed by SMBC Nikko Securities, Daiwa Securities and Mizuho Securities at ¥4bn each, and Mitsubishi UFJ Morgan Stanley Securities at ¥2bn. On the two-year notes, SMBC Nikko took the largest allocation at ¥6bn, ahead of Nomura at ¥5bn and Daiwa, Mizuho and Mitsubishi UFJ Morgan Stanley at ¥3bn apiece. All banks are buying the bonds outright as joint underwriters rather than on a best-efforts basis.
The filing sits under an existing shelf registration that took effect May 29, 2026 and runs through May 28, 2028, with a planned issuance ceiling of ¥100bn. This ¥40bn sale is the first drawdown against that shelf, leaving ¥60bn of registered capacity unused. For a reader tracking Japanese corporate credit, the useful takeaway is less about Sumitomo Chemical's balance sheet strategy, which the filing does not elaborate on beyond the refinancing purpose, and more about where two named domestic rating agencies and a five-bank underwriting syndicate are currently willing to clear an A-range chemical issuer's paper: just above 2% for two years, and just under 2.7% for five.